These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9871686)

  • 1. Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease.
    Borthwick AD; Weingarten G; Haley TM; Tomaszewski M; Wang W; Hu Z; Bedard J; Jin H; Yuen L; Mansour TS
    Bioorg Med Chem Lett; 1998 Feb; 8(4):365-70. PubMed ID: 9871686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human cytomegalovirus protease N(o) with monocyclic beta-lactams.
    Déziel R; Malenfant E
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1437-42. PubMed ID: 9871780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
    Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
    J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.
    Borthwick AD; Crame AJ; Ertl PF; Exall AM; Haley TM; Hart GJ; Mason AM; Pennell AM; Singh OM; Weingarten GG; Woolven JM
    J Med Chem; 2002 Jan; 45(1):1-18. PubMed ID: 11754575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam template.
    Borthwick AD; Angier SJ; Crame AJ; Exall AM; Haley TM; Hart GJ; Mason AM; Pennell AM; Weingarten GG
    J Med Chem; 2000 Nov; 43(23):4452-64. PubMed ID: 11087570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.
    Haley TM; Angier SJ; Borthwick AD; Montgomery DS; Purvis IJ; Smart DH; Bessant C; Van Wely C; Hart GJ
    J Mass Spectrom; 1998 Dec; 33(12):1246-55. PubMed ID: 9875526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolidine-5,5-trans-lactams. 1. Synthesis and incorporation into inhibitors of hepatitis C virus NS3/4A protease.
    Andrews DM; Carey SJ; Chaignot H; Coomber BA; Gray NM; Hind SL; Jones PS; Mills G; Robinson JE; Slater MJ
    Org Lett; 2002 Dec; 4(25):4475-8. PubMed ID: 12465916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; De Clercq E; Balzarini J; González-Muñiz R
    J Med Chem; 2005 Apr; 48(7):2612-21. PubMed ID: 15801851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiviral activity of monobactams inhibiting the human cytomegalovirus protease.
    Ogilvie WW; Yoakim C; Dô F; Haché B; Lagacé L; Naud J; O'Meara JA; Déziel R
    Bioorg Med Chem; 1999 Aug; 7(8):1521-31. PubMed ID: 10482444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of the antielastase activity of polycyclic β-lactams.
    Monleón LM; Díez-García F; Zamora H; Anaya J; Grande M; de Diego JG; Rodríguez FD
    Bioorg Chem; 2012 Dec; 45():29-35. PubMed ID: 23064125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Lactam derivatives as enzyme inhibitors: 1-peptidyl derivatives of 4-phenylazetidin-2-one as inhibitors of elastase and papain.
    Achilles K; Schirmeister T; Otto HH
    Arch Pharm (Weinheim); 2000 Aug; 333(8):243-53. PubMed ID: 11008374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthesis of azapeptidomimetic beta-lactam molecules as potential protease inhibitors.
    Malachowski WP; Tie C; Wang K; Broadrup RL
    J Org Chem; 2002 Dec; 67(25):8962-9. PubMed ID: 12467415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
    Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
    Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent beta-lactam inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Grand-Maître C; Guse I; Haché B; Kawai S; Naud J; O'Meara JA; Plante R; Déziel R
    Antivir Chem Chemother; 1998 Sep; 9(5):379-87. PubMed ID: 9875391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.
    Borthwick AD; Exall AM; Haley TM; Jackson DL; Mason AM; Weingarten GG
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1719-22. PubMed ID: 12067545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase synthesis of a library based on biphenyl-containing trypsin-like serine protease inhibitors.
    Shi S; Zhu S; Gerritz SW; Rachwal B; Ruan Z; Hutchins R; Kakarla R; Sofia MJ; Sutton J; Cheney D
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6477-80. PubMed ID: 19804972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and highly stereoselective synthesis of a beta-lactam inhibitor of the serine protease prostate-specific antigen.
    Annunziata R; Benaglia M; Cinquini M; Cozzi F; Puglisi A
    Bioorg Med Chem; 2002 Jun; 10(6):1813-8. PubMed ID: 11937339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease.
    Sperka T; Pitlik J; Bagossi P; Tözsér J
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3086-90. PubMed ID: 15893929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.
    Gopalsamy A; Lim K; Ellingboe JW; Mitsner B; Nikitenko A; Upeslacis J; Mansour TS; Olson MW; Bebernitz GA; Grinberg D; Feld B; Moy FJ; O'Connell J
    J Med Chem; 2004 Apr; 47(8):1893-9. PubMed ID: 15055990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.